Andrew Boyer

Andrew Boyer

Corporate Officer/Principal at AMNEAL PHARMACEUTICALS, INC.

Net worth: 6 M $ as of 2026-05-30

59 year
Health Technology
Process Industries
Technology Services

Profile

Andrew S.
Boyer
is currently Director at the Association for Accessible Medicines.
He is Chief Commercial Officer-Generics & Executive VP at Amneal Intermediate, Inc. since 2020.
Since 2023, he is Chief Commercial Officer-Generics & Biosciences at Amneal Pharmaceuticals, Inc. Formerly, Mr. Boyer was President & Chief Executive Officer at Teva Pharmaceuticals USA, Inc. He was Associate Director-Marketing at Generics Group, Inc. He worked as National Accounts Manager at Wyeth Holdings LLC.
From 2009 to 2016, he was Senior Vice President-Sales & Marketing at Actavis, Inc. He was Marketing Manager at Barr Laboratories, Inc. Mr. Boyer completed undergraduate studies at the State University of New York at Albany.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-11 426,072 ( 0.13% ) 6 M $ 2026-05-30

Andrew Boyer active positions

CompaniesPositionStart
AMNEAL PHARMACEUTICALS, INC. Corporate Officer/Principal 2023-11-06
Corporate Officer/Principal 2020-07-31
Director/Board Member -

Former positions of Andrew Boyer

CompaniesPositionEnd
Sales & Marketing 2016-07-31
Corporate Officer/Principal -
Corporate Officer/Principal -
Sales & Marketing -
Chief Executive Officer -
See the detail of Andrew Boyer's experience

Training of Andrew Boyer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Process Industries

Health Technology

Technology Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!